Uncoupling Protein 2 Knockout Mice Have Enhanced Insulin Secretory Capacity After a High-Fat Diet

  1. Jamie W. Joseph1,
  2. Vasilij Koshkin1,
  3. Chen-Yu Zhang2,
  4. Jing Wang1,
  5. Bradford B. Lowell2,
  6. Catherine B. Chan3 and
  7. Michael B. Wheeler1
  1. 1Departments of Medicine and Physiology, University of Toronto, Ontario, Canada
  2. 2Division of Endocrinology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
  3. 3Department of Anatomy and Physiology, Atlantic Veterinary College, University of Prince Edward Island, Prince Edward Island, Canada

    Abstract

    Uncoupling protein 2 (UCP2) may act as an important regulator of insulin secretion. In this study, β-cell function in UCP2-deficient mice was examined after a 45% high-fat diet (HFD) to assess its role during the development of diet-induced type 2 diabetes. HFD-fed UCP2 (−/−) mice have lower fasting blood glucose and elevated insulin levels when compared with wild-type (WT) mice. UCP2 (−/−) mice also have enhanced β-cell glucose sensitivity compared with WT mice after HFD, a result that is due in part to the deterioration of glucose responsiveness in WT mice. HFD-fed UCP2 (−/−) mice have increased insulin secretory capacity as a result of increased pancreatic β-cell mass and insulin content per islet. Islets from WT mice exposed to 0.5 mmol/l palmitate for 48 h have significantly reduced mitochondrial membrane potential, ATP concentrations, and glucose responsiveness compared with UCP2 (−/−) islets, suggesting that elevated UCP2 in WT mice increases proton leak and decreases mitochondrial ATP production. Highly increased carnitine palmitoyl transferase-1 gene expression in UCP2 (−/−) mice is suggestive of enhanced fatty acid oxidizing capacity, particularly after HFD stress. These results further establish UCP2 as a component in glucose sensing and suggest a possible new aspect of UCP2 function during the progression of type 2 diabetes.

    Footnotes

    • Address correspondence and reprint requests to Michael B. Wheeler, Department of Physiology, University of Toronto, 1 King’s College Circle, Room 3352, Toronto, ON, M5S 1A8, Canada. E-mail: michael.wheeler{at}utoronto.ca.

      Received for publication 15 November 2001 and accepted in revised form 4 July 2002.

      AUC, area under the curve; BrdU, 5-bromo-2′deoxyuridine; CPT-1, carnitine palmitoyltransferase 1; FFA, free fatty acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GSIS, glucose-stimulated insulin secretion; HFD, high-fat diet; IPGTT, intraperitoneal glucose tolerance test; ITT, insulin tolerance test; ROS, reactive oxygen species; UCP, uncoupling protein.

    « Previous | Next Article »Table of Contents